Identification and Characterization of Genomic Predictors of Sarcopenia and Sarcopenic Obesity Using UK Biobank Data
The substantial decline in skeletal muscle mass, strength, and gait speed is a sign of severe sarcopenia, which may partly depend on genetic risk factors. So far, hundreds of genome-wide significant single nucleotide polymorphisms (SNPs) associated with handgrip strength, lean mass and walking pace...
Main Authors: | Ekaterina A. Semenova, Erinija Pranckevičienė, Elvira A. Bondareva, Leysan J. Gabdrakhmanova, Ildus I. Ahmetov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/15/3/758 |
Similar Items
-
Editorial: (Osteo)sarcopenia & sarcopenic obesity, volume II
by: Ifigenia Kostoglou-Athanassiou, et al.
Published: (2023-11-01) -
Sarcopenic obesity and the risk of hospitalization or death from coronavirus disease 2019: findings from UK Biobank
by: Thomas J. Wilkinson, et al.
Published: (2022-01-01) -
Prevalence and associations of sarcopenia, obesity and sarcopenic obesity in end-stage knee osteoarthritis patients
by: Junyi Liao, et al.
Published: (2023-10-01) -
The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
by: Argyro Papadopetraki, et al.
Published: (2023-12-01) -
Prevalence of Sarcopenia and Sarcopenic Obesity in an Academic Total Joint Arthroplasty Practice
by: David E. DeMik, MD, PharmD, et al.
Published: (2022-08-01)